Global D-dimer Testing Market Expected to Reach USD 1.9 Billion in 2022: Transparency Market Research
According to a new report published by Transparency Market Research “D-dimer Testing Market (Testing Methods: Point-of-Care Tests and Laboratory Tests; Applications: Deep Vein Thrombosis, pulmonary Embolism and Disseminated Intravascular Coagulation) - Global Industry Analysis, Size, Share, Volume, Growth, Trends and Forecast, 2014 – 2022,” the global market for D-dimer testing was valued at USD 1.5 billion in 2013 and is expected to reach USD 1.9 billion in 2022, growing at a CAGR of 2.6 % from 2014 to 2022.
Browse the full D-dimer Testing Market Report: http://www.transparencymarketresearch.com/d-dimer-market.html
Over the years, gold standard for diagnostic tests such as venography and pulmonary angiography have been substituted by cost-effective point of care (POC) and laboratory-based D-dimer tests to rule out the presence of DVT/PE. These cost-effective POC and laboratory tests not only alleviate the cost burden of the patients, but also reduce the turnaround time of hospitals to screen and discharge patients; this is one of the primary agendas of health care reforms under the Hospital Readmissions Reduction Program (HRRP). Rising incidences of CVD, increasing expenditure in the form of funding or investment for the development of POC products, growing focus of both international and domestic players for the market, and a large number of R&D activities are expected to propel the demand for D-dimer testing products.
Geographically, the D-dimer testing market has been segmented into six major regions: North America, Europe, Asia Pacific, Latin America, MENA and Rest of the World. higher adoption and awareness regarding the association between CVD risks and D-dimer tests for exclusion of DVT, PE and DIC. In terms of volume, the number of D-dimer tests in North America stood at 95.1 million in 2013 and is expected to reach 126.4 million 2022. The region is expected to maintain its leadership position in terms of revenue by end of the forecast period due to the large and ever-increasing addressable patient population base. Additionally, development of rapid testing kits with improved accuracy and sensitivity, increase in the use of anticoagulant therapy, and high adoption rate of self-diagnostic kits are the major drivers fueling the growth of the D-dimer testing market in the region. Europe was the second largest market in 2013 due to extensive research activities, high cost of D-dimer kits and products, and large number of screening programs by health care institutes. It accounts for the largest share in terms of number of tests throughout the forecast period.
Get the full Press Release of D-dimer Testing Market: http://www.transparencymarketresearch.com/pressrelease/d-dimer-market.htm
Asia-Pacific, LATAM, MENA, and RoW demonstrate slow evolution, with a huge potential for market growth. Low awareness about the importance of excluding CVD risks, and thus D-dimer testing, is a major restraining factor in developing countries. Despite rapid economic growth in Asia Pacific, lack of awareness and availability of appropriate diagnostic centers for DVT at hospitals and private physician’s office is a major factor attributed to less cases reported for DVT. Countries such as Myanmar, Bhutan, Nepal, and Malaysia have least adoption rates for POC-based rapid diagnostic kits. The alarming increase in patient population would augment the demand for better diagnosis, and hence these economies would be lucrative markets for D-dimer tests.
The key players contributing to the growth of the global D-dimer testing market include Alere, Inc., Abbott Laboratories, Becton, Dickinson and Company, Beckman Coulter, Inc., Bio/Data Corporation, Corgenix, Helena Biosciences, F. Hoffman-La Roche Ltd., Thermo Fisher Scientific, Siemens Healthcare, Sysmex Corporation, and Trinity Biotech. Siemens Healthcare held the largest share in the global D-dimer testing market. It was followed by other companies such as Abbott Laboratories, Inc., Alere, and Roche Diagnostics.
The global D-dimer Testing Market is segmented as follows:
Global D-dimer Testing Market Revenue (USD Million) and Volume (Number of Tests), by Testing Method
o Point-of-Care Tests
o Laboratory Tests
o Coagulation Analyzers
o Clinical Chemistry Analyzers
Global D-dimer Testing Market Revenue (USD Million) and Volume (Number of Tests), by Applications
o Deep Vein Thrombosis
o Pulmonary Embolism
o Disseminated Intravascular Coagulation
Global D-dimer Testing Market Revenue (USD Million) and Volume (Number of Tests), by Geography
o North America
o Rest of Europe
o Asia Pacific
o Rest of Asia Pacific
o Latin America (LATAM)
o Rest of Latin America
o Middle East and North Africa (MENA)
o Saudi Arabia
o United Arab Emirates (U.A.E)
o Rest of MENA
o Rest of the World (RoW)
Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyze information.
Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.
Mr. Nachiket Ghumare
90 State Street, Suite 700
Albany, NY 12207
USA - Canada Toll Free: 866-552-3453